慢性荨麻疹患者生活质量现况及影响因素分析
摘要
关键词
全文:
PDF参考
[1]Maurer M, Zuberbier T, Metz M. The classification, pathogenesis, diagnostic workup, and management of urticaria: an update[J]. Handbook of experimental pharmacology, 2022, 268: 117-133.
[2]He L, Yi W, Huang X, et al. Chronic urticaria: advances in understanding of the disease and clinical management[J]. Clinical reviews in allergy & immunology, 2021, 61(3): 424-448.
[3]Gonçalo M, Gimenéz‐Arnau A, Al‐Ahmad M, et al. The global burden of chronic urticaria for the patient and society[J]. British Journal of Dermatology, 2021, 184(2): 226-236.
[4]Kroenke K, Spitzer RL, Wiliams JB. The PHQ-9: validity of a brief depression severity measure[J]. Journal of General interna Medicine, 2001, 16(9): 606-613.
[5]Spitzer RL, Kroenke K, Wiliams JBW, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7[J]. Archives of internal Medicine, 2006, 166(10): 1092-1097.
[6]Finlay A, Khan G. Dermatology Life Quality Index(DLQl): a simple practical measure for routine clinical use[J]. Clinical And Experimental Dermatology, 1994, 19(3): 210-216.
[7]王晓玲,赵天恩,张喜芹.简体中文版皮肤病生活质量指标信度和效度初探[J].中华流行病学杂志,2004,25(9):791-793.
[8]中华医学会皮肤性病学分会荨麻疹研究中心,中国荨麻疹诊疗指南(2018版)[J].中华皮肤科杂志,2019,52(1):1-5.
[9]Kao C, Huang J, Ou L, et al. The prevalence, severity and seasonal variations of asthma, rhinitis and eczema in Taiwanese school children[J]. Pediatr Allergy Immunol, 2005, 16(5): 408-415.
[10]Lee N, Lee J, Lee H, et al. Epidemiology of chronic urticaria in Korea using the Korean health insurance database, 2010-2014[J]. Allergy, asthma & immunology research, 2017, 9(5): 438-445.
[11]Du-Thanh A. Urticaire chronique [Chronic urticaria][J]. La Revue du praticien, 2021, 71(3): 293-297.
[12]Kolkhir P, Altrichter S, Munoz M, et al. New treatments for chronic urticaria[J]. Annals of allergy, asthma & immunology, 2020, 124(1): 2-12.
[13]曹瑜,郑辉烈,刘智涛,等.1990-2019年中国荨麻疹疾病负担现状及趋势[J].中国皮肤性病学杂志,2022,36(8):905-910+919.
[14]李春鲜,谢波,段瑞,等.奥马珠单抗治疗慢性荨麻疹的临床疗效观察[J].皮肤病与性病,2024,46(2):108-111.
[15]罗婕,李垚莹,宋志强,等.421例慢性荨麻疹患者皮肤病生活质量的评估[J].中国麻风皮肤病杂志,2012,28(11):776-778.
[16]Weldon D. Quality of life in patients with urticaria and angioedema: assessing burden of disease[J]. Allergy and asthma proceedings, 2014, 35(1): 4-9.
[17]Huang Y, Jing D, Su J, et al. Association of night shift work with chronic spontaneous urticaria and effect modification by circadian dysfunction among workers[J]. Frontiers in Public Health, 2021, 9: 751579.
[18]Balp M, Lopes N, Tian H, et al. Economic and humanistic burden of chronic spontaneous urticaria in Brazil: impact on work productivity, resource utilization and quality of life[J]. Value in Health, 2016, 19(7): A617.
[19]Rani S, Singh S, Kumar D, Dabas S, Ritu K. Assessment of depression, anxiety, and stress in chronic urticaria and its correlation with disease severity[J]. Annals of Allergy Asthma & Immunology, 2022, 128(3): 330-331.
[20]Nagayama K, Watai K, Sekiya K, et al. Association between the severity of chronic spontaneous urticaria and sleep-disordered breathing[J]. Allergology International, 2022, 71(1): 103-108.
[21]Meguid A, Awad M, Noaman M, et al. Does chronic urticaria affect quality of sleep and quality of life?[J]. Journal of public health research, 2024, 13(2): 66-70.
[22]寇硕.社会经济地位与中青年人群健康的关系及压力的中介作用研究[D].浙江中医药大学,2023.
[23]Gil-Soon C, Young-Hee N, Chan-Sun P, et al. Anxiety, depression, and stress in Korean patients with chronic urticaria[J]. The Korean journal of internal medicine, 2020, 35(6): 1507-1516.
[24]朱海军,庞雅男,李芳芳,等.慢性荨麻疹患者生活质量评估及影响因素分析[J].中国中西医结合皮肤性病学杂志,2020,19(6):536-539.
[25]Jankowska-Konsur A, Reich A, Szepietowski J. Clinical character-istics and epidemiology of chronic urticaria: a nationwide, multicentre study on 1091 patients[J]. Postepy Dermatol Alergol, 2019, 36: 184-191.
[26]蒋钰.慢性荨麻疹患者的成瘾行为及患者可接受症状状态的研究[D].中南大学,2023.
Refbacks
- 当前没有refback。